T32 CTEng (Cellular and Tissue Engineering) Training Program
T32 CTEng(细胞和组织工程)培训计划
基本信息
- 批准号:10641891
- 负责人:
- 金额:$ 47.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
This application requests funding for Years 31-35 of our highly successful and impactful NIGMS
Biotechnology T32 Program on Cell and Tissue Engineering (CTEng). The objective of CTEng is to
provide innovative and integrated training for predoctoral engineering students in cell and
tissue engineering to develop future leaders for these biotechnology industries. CTEng will
provide an innovative and integrated training program comprising (i) formal courses on engineering
fundamentals, biosciences, bioengineering, and business principles; (ii) bi-weekly meetings with faculty
with topics rotating among journal club discussion, research presentation, faculty and industry career
discussions, and mentorship training; (iii) industrial visits and internships; (iii) an industry mentor
program; (iv) an annual cell and tissue engineering conference; (v) a regional T32 Biotechnology career
development workshop; and (vi) training in the responsible conduct of research and methods for
enhancing reproducibility. Georgia Tech provides an outstanding, highly collaborative and integrative
training and research environment in cell and tissue engineering. The particular strengths, and in many
instances unique features, of our program include (1) one of the largest faculties in the nation,
comprising many of the leading researchers in cell and tissue engineering, who provide a dynamic,
broad and deep critical mass of expertise; (2) recognized leadership in engineering and medicine (with
our partner Emory University School of Medicine) and especially at their intersection; (3) outstanding
research facilities and infrastructure; (4) a curriculum of innovative training components emphasizing
developing interdisciplinary researchers with strong leadership and communication skills; (5) a dynamic
ecosystem with multi-faceted connection points to industry and entrepreneurship and
commercialization; (6) a richly diverse and supportive culture; and (7) quality programs for the
recruitment, training and graduation of underrepresented minority students that are among the largest
and most successful in the nation. CTEng preceptors will nominate predoctoral students from our
BioEngineering, joint GT/Emory Biomedical Engineering, Chemical and Biomolecular Engineering, and
Mechanical Engineering programs at the end of their first year, and CTEng will support selected
trainees for the second and third years of graduate school. We request support for 9 students per year,
which is the current funding level. Graduates of CTEng will exhibit high research productivity in terms
of publications and presentations and will transition into impactful careers in academic, industry, and
government and become leaders of the cell and tissue engineering biotechnology industries.
项目摘要
该申请要求为我们非常成功且有影响力的裸体带来31 - 35年的资金
生物技术T32细胞和组织工程计划(CTENG)。 Cteng的目的是
为细胞中的专业工程专业学生提供创新和集成的培训
组织工程以发展这些生物技术行业的未来领导者。 Cteng Will
提供一项创新且集成的培训计划,包括(i)工程正式课程
基本面,生物科学,生物工程和商业原则; (ii)每两周与教师会议
随着日记俱乐部讨论,研究演示,教职员工和行业职业的主题旋转
讨论和指导培训; (iii)工业访问和实习; (iii)行业导师
程序; (iv)一年一度的细胞和组织工程会议; (v)区域T32生物技术职业
开发研讨会; (vi)负责任的研究和方法的培训
增强可重复性。佐治亚理工学院提供了出色,高度协作和综合的
细胞和组织工程的培训和研究环境。特殊的优势,在许多人中
我们计划的独特功能包括(1)美国最大的学院之一,
包括细胞和组织工程领域的许多领先研究人员,他们提供了动态的
广泛而深层的专业知识; (2)公认的工程和医学领导
我们的合伙人埃默里大学医学院,尤其是在交叉路口; (3)杰出
研究设施和基础设施; (4)强调创新培训组件的课程
发展具有强大领导能力和沟通能力的跨学科研究人员; (5)动态
具有多方面连接的生态系统指向行业和企业家精神和
商业化; (6)一种丰富多样的支持文化; (7)质量计划
招聘,培训和毕业代表人数不足的少数族裔学生
而且在全国最成功。 CTENG主持人将提名我们的前学生
生物工程,联合GT/Emory生物医学工程,化学和生物分子工程以及
第一年结束时的机械工程计划,Cteng将支持选定的
学员在研究生院第二和第三年。我们要求每年9名学生的支持,
这是当前的资金水平。 CTENG的毕业生将以术语表现出较高的研究生产力
出版物和演讲,并将过渡到学术,工业和
政府并成为细胞和组织工程生物技术行业的领导者。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Label-free microfluidic isolation of functional and viable lymphocytes from peripheral blood mononuclear cells.
- DOI:10.1063/5.0161047
- 发表时间:2023-09
- 期刊:
- 影响因子:3.2
- 作者:Abhishek Raj;Katily Ramirez;Katherine M. Young;Nicholas E. Stone;Peter Shankles;Mehdia Nadeem Rajab Ali;Anthony Malik Compton;Wilbur A. Lam;Alexander Alexeev;Todd Sulchek
- 通讯作者:Abhishek Raj;Katily Ramirez;Katherine M. Young;Nicholas E. Stone;Peter Shankles;Mehdia Nadeem Rajab Ali;Anthony Malik Compton;Wilbur A. Lam;Alexander Alexeev;Todd Sulchek
Comparing Brain and Blood Lipidome Changes following Single and Repetitive Mild Traumatic Brain Injury in Rats.
- DOI:10.1021/acschemneuro.3c00603
- 发表时间:2024-01-17
- 期刊:
- 影响因子:5
- 作者:Pulliam, Alexis N.;Gier, Eric C.;Gaul, David A.;Moore, Samuel G.;Fernandez, Facundo M.;Laplaca, Michelle C.
- 通讯作者:Laplaca, Michelle C.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edward A. Botchwey其他文献
Edward A. Botchwey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edward A. Botchwey', 18)}}的其他基金
T32 CTEng (Cellular and Tissue Engineering) Training Program
T32 CTEng(细胞和组织工程)培训计划
- 批准号:
10420388 - 财政年份:2022
- 资助金额:
$ 47.75万 - 项目类别:
Artery biomechanics and vascular damage in sickle cell disease
镰状细胞病的动脉生物力学和血管损伤
- 批准号:
10390381 - 财政年份:2021
- 资助金额:
$ 47.75万 - 项目类别:
Artery biomechanics and vascular damage in sickle cell disease
镰状细胞病的动脉生物力学和血管损伤
- 批准号:
10606485 - 财政年份:2021
- 资助金额:
$ 47.75万 - 项目类别:
Regenerative Immunotherapy using light triggered in vivo activation of adhesive peptides
使用光触发体内粘附肽激活的再生免疫疗法
- 批准号:
10252435 - 财政年份:2020
- 资助金额:
$ 47.75万 - 项目类别:
Immune Modulatory Nanofibers for Skeletal Muscle Reconstruction
用于骨骼肌重建的免疫调节纳米纤维
- 批准号:
9565183 - 财政年份:2017
- 资助金额:
$ 47.75万 - 项目类别:
2015 Biomaterials & Tissue Engineering Gordon Research Conference and Gordon Research Seminar
2015年生物材料
- 批准号:
8986494 - 财政年份:2015
- 资助金额:
$ 47.75万 - 项目类别:
Therapeutic S1P Drug Targets for Cranial Bone Repair
颅骨修复的治疗性 S1P 药物靶点
- 批准号:
8069853 - 财政年份:2009
- 资助金额:
$ 47.75万 - 项目类别:
Therapeutic S1P Drug Targets for Cranial Bone Repair
颅骨修复的治疗性 S1P 药物靶点
- 批准号:
8543695 - 财政年份:2009
- 资助金额:
$ 47.75万 - 项目类别:
Phospholipid Growth Factors for Therapeutic Arteriogenesis and Tissue Engineering
用于治疗性动脉生成和组织工程的磷脂生长因子
- 批准号:
8895064 - 财政年份:2009
- 资助金额:
$ 47.75万 - 项目类别:
Therapeutic S1P Drug Targets for Cranial Bone Repair
颅骨修复的治疗性 S1P 药物靶点
- 批准号:
7858504 - 财政年份:2009
- 资助金额:
$ 47.75万 - 项目类别:
相似国自然基金
基于计划行为理论公众实施心肺复苏的行为机制及急救培训策略研究
- 批准号:82160647
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
共享航次计划青年科考人员培训对象及方案设计战略研究
- 批准号:
- 批准年份:2020
- 资助金额:100 万元
- 项目类别:专项基金项目
相似海外基金
In vivo 2-photon imaging of retinal biochemistry before and after retinal organoid transplantation
视网膜类器官移植前后视网膜生物化学的体内2光子成像
- 批准号:
10643273 - 财政年份:2023
- 资助金额:
$ 47.75万 - 项目类别:
Michigan Otolaryngology Research Education (MORE)
密歇根耳鼻喉科研究教育(更多)
- 批准号:
10721751 - 财政年份:2023
- 资助金额:
$ 47.75万 - 项目类别:
Elucidating the Role of Microenvironment Mechanics in Regulating Cardiac Myofibroblast Plasticity
阐明微环境力学在调节心脏肌成纤维细胞可塑性中的作用
- 批准号:
10570135 - 财政年份:2023
- 资助金额:
$ 47.75万 - 项目类别:
The Role of EpCAM Glycosylation in Breast Cancer Metastasis
EpCAM 糖基化在乳腺癌转移中的作用
- 批准号:
10605857 - 财政年份:2023
- 资助金额:
$ 47.75万 - 项目类别:
Dental-Biomedical Engineering Scholars Training (D-Best) Program
牙科生物医学工程学者培训(D-Best)计划
- 批准号:
10845831 - 财政年份:2023
- 资助金额:
$ 47.75万 - 项目类别: